ARVO
ARVO 2017 - Sylentis's Posters
Category: ARVO
NEW PRESS RELEASE >> Sylentis announces new preclinical and clinical data for its SYL1001 molecule during ARVO 2017
Groundbreaking research in Dry Eye Disease will be presented at the Annual Meeting of the Association of Research in Vision and Ophthalmology (ARVO) in Baltimore, Maryland from May 7-11, 2017.
Three Sylentis’ abstracts were selected for poster presentations.